跳至主要内容
临床试验/ACTRN12614001143617
ACTRN12614001143617招募中未知

Determining Circulating Tumour Cells (CTC) and other rare cells in cancer patients before and after treatment and for early detection screening using ISET (Isolation by Size of Epithelial/ Trophoblastic Tumour Cells) technology

Dr Karin Ried0 个研究点目标入组 2,000 人开始时间: 2014年10月29日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • treatment effectiveness: Patient diagnosed with cancer;
  • Have previously received (at least 3 weeks ago) or will receive treatment within one week;
  • treatment may include chemotherapy, radiotherapy, hyperthermia, intravenous Vitamin C, or other complementary treatment as prescribed by the treating physician;
  • Early detection screening: Patients with a family history of cancer or patients with chronic disease, or as part of a health check

排除标准

  • no exclusion

研究者

发起方
Dr Karin Ried

相似试验